Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cevayir Coban

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Cell Stem Cell|June 29, 2023
Controlling genetic heterogeneity in gene-edited hematopoietic stem cells by single-cell expansionHans Jiro Becker, Reiko Ishida, Adam C Wilkinson, et al.
Journal of Virology|June 16, 2006
Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunityFumihiko Takeshita, Toshiyuki Tanaka, Tomoko Matsuda, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2021
TBK1 and IKKε act like an OFF switch to limit NLRP3 inflammasome pathway activationFabian A Fischer, Linda F M Mies, Sohaib Nizami, et al.
Science Immunology|August 8, 2017
<i>Plasmodium</i> products persist in the bone marrow and promote chronic bone lossMichelle S J Lee, Kenta Maruyama, Yukiko Fujita, et al.
International Immunology|April 20, 2024
MyD88 in osteoclast and osteoblast lineages differentially controls bone remodeling in homeostasis and malariaJalal Alshaweesh, Rashmi Dash, Michelle S J Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2014
Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonistKouji Kobiyama, Taiki Aoshi, Hirotaka Narita, et al.
Frontiers in Immunology|March 27, 2024
5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activationBurcu Temizoz, Takayuki Shibahara, Kou Hioki, et al.
Nature Immunology|November 16, 2005
A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNAKen J Ishii, Cevayir Coban, Hiroki Kato, et al.
Cell Host & Microbe|February 2, 2010
Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9Cevayir Coban, Yoshikatsu Igari, Masanori Yagi, et al.
Frontiers in Immunology|December 6, 2018
DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split VaccinationTomoya Hayashi, Masatoshi Momota, Etsushi Kuroda, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Cell Stem Cell|June 29, 2023
Controlling genetic heterogeneity in gene-edited hematopoietic stem cells by single-cell expansionHans Jiro Becker, Reiko Ishida, Adam C Wilkinson, et al.
Journal of Virology|June 16, 2006
Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunityFumihiko Takeshita, Toshiyuki Tanaka, Tomoko Matsuda, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2021
TBK1 and IKKε act like an OFF switch to limit NLRP3 inflammasome pathway activationFabian A Fischer, Linda F M Mies, Sohaib Nizami, et al.
Science Immunology|August 8, 2017
<i>Plasmodium</i> products persist in the bone marrow and promote chronic bone lossMichelle S J Lee, Kenta Maruyama, Yukiko Fujita, et al.
International Immunology|April 20, 2024
MyD88 in osteoclast and osteoblast lineages differentially controls bone remodeling in homeostasis and malariaJalal Alshaweesh, Rashmi Dash, Michelle S J Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2014
Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonistKouji Kobiyama, Taiki Aoshi, Hirotaka Narita, et al.
Frontiers in Immunology|March 27, 2024
5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activationBurcu Temizoz, Takayuki Shibahara, Kou Hioki, et al.
Nature Immunology|November 16, 2005
A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNAKen J Ishii, Cevayir Coban, Hiroki Kato, et al.
Cell Host & Microbe|February 2, 2010
Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9Cevayir Coban, Yoshikatsu Igari, Masanori Yagi, et al.
Frontiers in Immunology|December 6, 2018
DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split VaccinationTomoya Hayashi, Masatoshi Momota, Etsushi Kuroda, et al.
Pageof 10